Cannell Capital - Q4 2022 holdings

$496 Million is the total value of Cannell Capital's 89 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 3.3% .

 Value Shares↓ Weighting
GBLI  GLOBAL INDEMNITY GROUP LLC$1,834,031
+5.6%
78,6800.0%0.37%
-6.8%
PNRG  PRIMEENERGY RESOURCES CORP$1,136,520
+8.9%
13,0830.0%0.23%
-4.2%
WINA  WINMARK CORP$518,826
+9.0%
2,2000.0%0.10%
-3.7%
YNDX  YANDEX N V$487,779
-78.3%
341,1040.0%0.10%
-81.0%
GTX  GARRETT MOTION INC$331,470
+34.7%
43,5000.0%0.07%
+19.6%
 VIGIL NEUROSCIENCE INC$100,550
+37.7%
8,0440.0%0.02%
+17.6%
SBTX  SILVERBACK THERAPEUTICS INC$80,199
+60.4%
9,4020.0%0.02%
+45.5%
LVTX  LAVA THERAPEUTICS NV$62,843
-23.4%
17,9550.0%0.01%
-31.6%
 OMEGA THERAPEUTICS INC$53,862
+5.6%
9,4330.0%0.01%
-8.3%
TBLAW  TABOOLA.COM LTD*w exp 06/29/202$52,174
+33.8%
106,3910.0%0.01%
+22.2%
GRPH  GRAPHITE BIO INC$47,503
+5.6%
14,3080.0%0.01%0.0%
RICK  RCI HOSPITALITY HLDGS INC$42,867
+42.9%
4600.0%0.01%
+28.6%
 XILIO THERAPEUTICS INC$45,797
-8.4%
17,0250.0%0.01%
-18.2%
FSTX  F-STAR THERAPEUTICS INC$46,420
+22.2%
7,3450.0%0.01%0.0%
GANX  GAIN THERAPEUTICS INC$38,721
-3.2%
12,3710.0%0.01%
-11.1%
ADAG  ADAGENE INCads$38,422
+3.8%
28,9980.0%0.01%0.0%
OVID  OVID THERAPEUTICS INC$42,073
+0.2%
22,6200.0%0.01%
-20.0%
KEQU  KEWAUNEE SCIENTIFIC CORP$39,588
-10.0%
2,4820.0%0.01%
-20.0%
CYT  CYTEIR THERAPEUTICS INC$32,479
-14.5%
19,6840.0%0.01%
-22.2%
BNR  BURNING ROCK BIOTECH LTDsponsored ads$36,547
-6.3%
16,2430.0%0.01%
-22.2%
ANGN  ANGION BIOMEDICA CORP$32,611
-11.9%
40,1810.0%0.01%
-12.5%
GRCL  GRACELL BIOTECHNOLOGIES INCsponsored ads$32,888
-28.5%
14,2990.0%0.01%
-36.4%
OMIC  SINGULAR GENOMICS SYSTEMS IN$28,634
-20.5%
14,2460.0%0.01%
-25.0%
FIXX  HOMOLOGY MEDICINES INC$27,673
-20.9%
21,9630.0%0.01%
-25.0%
GBIO  GENERATION BIO CO$30,528
-25.5%
7,7680.0%0.01%
-33.3%
 IO BIOTECH INC$28,966
-14.8%
12,5940.0%0.01%
-25.0%
AUTL  AUTOLUS THERAPEUTICS PLCspon ads$31,987
-11.1%
16,8350.0%0.01%
-25.0%
 TSCAN THERAPEUTICS INC$22,732
-49.5%
14,6660.0%0.01%
-50.0%
 PARDES BIOSCIENCES INC$27,263
-9.1%
16,1320.0%0.01%
-28.6%
 ADAGIO THERAPEUTICS INC$18,974
-52.6%
12,6490.0%0.00%
-55.6%
 YANDEX N Vcall$01,8300.0%0.00%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-02-14
Signatures

The EDGAR filing(s) were signed by:

About Cannell Capital

Cannell Capital is a well-known investment firm that specializes in small-cap stocks. The company was founded in 1992 by J. Carlo Cannell, who serves as the CEO and Chief Investment Officer. Cannell Capital has a reputation for being an activist investor, meaning that they take an active role in the companies they invest in, often pushing for changes in management or strategy.

One of the key figures at Cannell Capital is the COO, James A. Mitarotonda. Mitarotonda has been with the company since 1993 and is known for his expertise in corporate governance and shareholder activism. He has been involved in a number of high-profile proxy battles, including one with the restaurant chain Denny's in 2010.

Cannell Capital has a diverse portfolio of investments, with a focus on small-cap companies in the technology, healthcare, and consumer goods sectors. The company has a long-term investment strategy, often holding onto stocks for several years. This approach has led to some impressive returns for the firm's investors.

While Cannell Capital is known for its activism, the company also has a reputation for being a responsible investor. They take environmental, social, and governance (ESG) factors into account when making investment decisions, and have been recognized for their commitment to sustainability.

Overall, Cannell Capital is a respected player in the world of small-cap investing, with a track record of success and a commitment to responsible investing practices.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
BUILD-A-BEAR WORKSHOP INC39Q3 20237.1%
NETWORK-1 TECHNOLOGIES INC36Q3 20230.8%
A-MARK PRECIOUS METALS INC32Q3 20230.6%
BERKSHIRE HATHAWAY INC DEL28Q1 20202.1%
HERITAGE CRYSTAL CLEAN INC27Q3 20237.1%
BERKSHIRE HATHAWAY INC DEL26Q3 20191.6%
SANDRIDGE ENERGY INC25Q4 20224.5%
MANITEX INTL INC25Q3 20230.6%
THESTREET INC24Q1 20193.2%
PERMA-PIPE INTL HLDGS INC24Q3 20231.9%

View Cannell Capital's complete holdings history.

Latest significant ownerships (13-D/G)
Cannell Capital Q4 2022 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
SPORTSMAN'S WAREHOUSE HOLDINGS, INC.September 18, 20233,743,54110.0%
AUDIOEYE INCFebruary 13, 2023818,7257.1%
PowerFleet, Inc.February 13, 20232,106,3125.8%
TILE SHOP HOLDINGS, INC.February 13, 20232,453,3275.5%
LEE ENTERPRISES, IncDecember 08, 2022546,9359.2%
EMCORE CORPAugust 12, 20221,573,2424.2%
1847 Goedeker Inc.February 14, 202210,146,8359.5%
Spark Networks SESeptember 01, 20211,118,4764.3%
SANDRIDGE ENERGY INCFebruary 16, 20213,173,7218.8%
DESTINATION XL GROUP, INC.July 29, 20202,304,5864.5%

View Cannell Capital's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G2024-02-13

View Cannell Capital's complete filings history.

Compare quarters

Export Cannell Capital's holdings